| 000 | 01183 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515053812.0 | ||
| 264 | 0 | _c20070222 | |
| 008 | 200702s 0 0 eng d | ||
| 022 | _a0323-3847 | ||
| 024 | 7 |
_a10.1002/bimj.200610298 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHasenclever, Dirk | |
| 245 | 0 | 0 |
_aMultiple targeted therapies: is there a place for Vach type-3 or type-4 design trials. _h[electronic resource] |
| 260 |
_bBiometrical journal. Biometrische Zeitschrift _cDec 2006 |
||
| 300 |
_a911-3; discussion 914-5 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiometry _xmethods |
| 650 | 0 | 4 |
_aClinical Trials, Phase III as Topic _xmethods |
| 650 | 0 | 4 | _aData Interpretation, Statistical |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aResearch Design |
| 773 | 0 |
_tBiometrical journal. Biometrische Zeitschrift _gvol. 48 _gno. 6 _gp. 911-3; discussion 914-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/bimj.200610298 _zAvailable from publisher's website |
| 999 |
_c16804052 _d16804052 |
||